Effect of exacerbation history on clinical response to dupilumab in moderate-to-severe uncontrolled asthma.

MLA

Corren, Jonathan, et al. “Effect of Exacerbation History on Clinical Response to Dupilumab in Moderate-to-Severe Uncontrolled Asthma.” The European Respiratory Journal, vol. 58, no. 4, Oct. 2021. EBSCOhost, https://doi.org/10.1183/13993003.04498-2020.

APA

Corren, J., Katelaris, C. H., Castro, M., Maspero, J. F., Ford, L. B., Halpin, D. M. G., Rice, M. S., Radwan, A., Deniz, Y., Rowe, P. J., Teper, A., & Djandji, M. (2021). Effect of exacerbation history on clinical response to dupilumab in moderate-to-severe uncontrolled asthma. The European Respiratory Journal, 58(4). https://doi.org/10.1183/13993003.04498-2020

Chicago

Corren, Jonathan, Constance H Katelaris, Mario Castro, Jorge F Maspero, Linda B Ford, David M G Halpin, Megan S Rice, et al. 2021. “Effect of Exacerbation History on Clinical Response to Dupilumab in Moderate-to-Severe Uncontrolled Asthma.” The European Respiratory Journal 58 (4). doi:10.1183/13993003.04498-2020.